Helen Davis

As COO/CFO Ashim Gupta prepares for a key investor conference, UiPath aims to prove its 'agentic automation' strategy can deliver sustained growth.

A new nationwide study reveals a massive gap in care for heart failure patients, costing lives and billions. Why are proven, cheap medications being overlooked?

Blink now accepts crypto at its EV chargers, a strategic move to attract younger drivers. But what does this mean for the industry and for you?

EdgeCortix's SAKURA-II processor survives brutal radiation tests, paving the way for intelligent, real-time decision-making on satellites and the Moon.

With a top neurologist at the helm and a breakthrough platform, NanoMosaic aims to decentralize brain health diagnostics and reshape drug development.

Lazard Asset Management creates a new CIO role, appointing Eric Van Nostrand to unify its global investment platform amid fierce industry competition.

With new CEO Libby Morgan, media agency NOVUS pivots from hyperlocal buyer to a full-funnel growth partner, signaling a major industry shift.

Shipping giant Costamare Inc. reaffirms its financial strength with consistent shareholder payouts, backed by a strong market and strategic growth.

A new $1,000 grant aims to foster compassion in future doctors, but its founder, a prominent psychiatrist, recently pleaded guilty to healthcare fraud.

In a city scarred by wildfires and division, L.A. Works' MLK Day festival rallies thousands to build a 'Beloved Community' through hands-on action.

A strategic acquisition, backed by Argonne Capital, sets the stage for major expansion in Texas's booming specialized lighting and holiday décor market.

Ultragenyx's stock plummets after its Osteogenesis Imperfecta drug fails to reduce fractures, a major blow for patients and a test of the firm's pipeline.

Branded Legacy just wiped out $1M in legacy debt. The move is part of a radical overhaul by new management aimed at rebuilding investor confidence.

Finnish tech firm Bittium secures a landmark €120M licensing deal with Spain's Indra, boosting its finances and enabling sovereign defense technology.

MySize Inc. projects a pivotal 2026 after a strategic overhaul, but a history of losses and a plummeting stock price fuel deep market skepticism.

Syra Health appoints Gregory R. Alexander as CEO, banking on his military discipline and record of scaling healthcare firms to drive its next growth phase.

The biotech upstart will present a bold pipeline, including a head-to-head trial against a market leader and a first-in-class autoimmune eye disease therapy.

Celltrion's SteQeyma autoinjector gets a CHMP nod, enhancing patient care and intensifying competition in Europe's crowded biosimilar market.

ExGen Resources is diversifying into Latin America, signing its first silver stream deal on a past-producing Chilean gold mine as it nears a major merger.

Amid rising food insecurity, US Foods delivered nearly $12.5M in aid, powered by a 70% surge in employee volunteerism and new strategic programs.